KIRO 7 Now
Medication expected to be ok'd for weight loss A drug that treats Type 2 diabetes could become the best-selling medication in history if approved by the U.S. Food and Drug Administration to also treat obesity. (Aldo Ottaviani – Italy/Getty Images/iStockphoto)
A drug that treats Type 2 diabetes could become the best-selling medication in history if approved by the U.S. Food and Drug Administration to treat obesity.
>> Read more trending news
The drug, tirzepatide, was created by Eli Lilly and approved as a diabetes treatment last year. While studying the drug as a treatment for diabetes, researchers also found it showed impressive results in clinical trials for weight loss.
The clinical trial showed that a higher dose of the drug reduced appetite and improved the body’s ability to break down sugar and fat, leading to a 22.5% loss in body weight for patients in the study. The average weight loss for those in the study was 52 pounds.
The drug would be expensive – around $1,000 to $1,200 a month – and would likely not be paid for as a weight loss drug by most insurance companies. Annual sales of tirzepatide could hit a record $48 billion, Bank of America analyst Geoff Meacham told NBC News.
Tirzepatide, sold under the brand name Mounjaro, is covered by most insurance companies as a treatment for diabetes.
According to the Centers for Disease Control and Prevention, in 2020, nearly 42% of Americans were obese. Black Americans had the highest adult obesity level at 49.9%.
Hispanic adults had an obesity rate of 45.6%; white adults had an obesity rate of 41.4%, and Asian adults had an obesity rate of 16.1%.
The estimated annual medical cost of treating those with obesity in the U.S. was nearly $173 billion in 2019.
A second trial to test tirzepatide’s effectiveness as a weight loss treatment should be completed in April, according to Healthline.
The FDA’s move to fast-track a decision on whether to approve the drug as a weight loss treatment allows trial data to be reviewed as it is gathered.
Other diabetes medications are used for weight loss, with critics slamming the practice, saying it has caused a shortage of the drugs desperately needed to treat diabetes.
Wegovy has been used by celebrities for weight loss, according to a story from “60 Minutes.”
Semaglutide, used in the diabetes drugs Ozempic and Wegovy, was shown to produce a nearly 16 percent reduction in body mass index in both adolescents and adults in clinical trials. Semaglutide costs around $1,200 a month.
Both Ozempic and Wegovy are listed as “currently on shortage” on the FDA’s website.
©2022 Cox Media Group
© 2022 Cox Media Group. This station is part of Cox Media Group Television. Learn about careers at Cox Media Group. By using this website, you accept the terms of our Visitor Agreement and Privacy Policy, and understand your options regarding Ad Choices.